Diagnostic method for predicting the risk of cancer recurrence based on histone macroH2A isoforms

Details for Australian Patent Application No. 2010268389 (hide)

Owner Thoraxklinik-Heidelberg gGmbH EMBL European Molecular Biology Laboratory

Inventors Ladurner, Andreas; Sporn, Judith; Muley, Thomas

Agent Pizzeys

Pub. Number AU-A-2010268389

PCT Pub. Number WO2011/000573

Priority 09008679.4 02.07.09 EP

Filing date 2 July 2010

Wipo publication date 6 January 2011

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

12 January 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Dec 2011

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/000573 Priority application(s): WO2011/000573

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010268400-Methods and means for obtaining plants with enhanced glyphosate tolerance

2010268372-Polarization device and implantation device